Cypress Introduces New Document Management Tool for

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jul 30, 2014 at 8:15 AM

Cypress Introduces New Document Management Tool for Streamlined Navigation

SAN JOSE, CA--(Marketwired - Jul 30, 2014) - Cypress Semiconductor Corp. ( NASDAQ : CY ) today introduced a document management tool that helps users quickly search its portfolio of rich online technical content. The new Cypress Document Manager (CDM) allows users to navigate more than 60,000 Cypress documents using keyword searches combined with document filters for product, application, document type and language. CDM makes it simple and efficient for users to make sure they have the most up to date files as new document revisions are published to the Cypress website.

"Cypress is committed to providing high-quality documentation, and we developed Cypress Document Manager specifically to make these resources more accessible. CDM helps engineers quickly find the application note or package drawing they need, right when they need it," said Alan Hawse, Executive Vice President of Software. "As part of the CDM project, we've now begun classifying our training and application notes by expertise level. This has been a common customer request from users looking to find beginner materials, and it is now available in just a couple of clicks within the tool."

CDM manages documentation for all Cypress products; documentation for PSoC programmable systems-on-chip, touch-sensing solutions, memories and USB controllers can all be found, viewed and managed within a single tool. CDM can open documents located on the Web or downloaded to a user's desktop. Users can preview documents before downloading, and then, with a single click, download the document to their PC. CDM also simplifies keeping local documents up-to-date with a single-click navigation that allows users to check all local documents for newer revisions available on the Cypress website.

CDM provides intuitive document navigation and filtering. With the ability to filter all Cypress documentation by product, application, document type, language and expertise level, users can quickly find the collateral required for their project. Keywords can be added in conjunction with filters to further specify a precise set of needed documents. The resulting list of documents is easy to browse through, as they can be sorted by title, language, relevance, file type and version.

Availability Cypress Document Manager is available today from www.cypress.com/cdm .

Follow Cypress Online

Join the Cypress Developer Community .
Follow @CypressSemi on Twitter .
Visit us on Facebook and LinkedIn .
View Cypress videos on our Video Library or YouTube .

About Cypress Cypress delivers high-performance, mixed-signal, programmable solutions that provide customers with rapid time-to-market and exceptional system value. Cypress offerings include the flagship PSoC^® 1, PSoC 3, PSoC 4 and PSoC 5LP programmable system-on-chip families. Cypress is the world leader in capacitive user interface solutions including CapSense^® touch sensing, TrueTouch^® touchscreens, and trackpad solutions for notebook PCs and peripherals. Cypress is a world leader in USB controllers, which enhance connectivity and performance in a wide range of consumer and industrial products. Cypress is also the world leader in SRAM and nonvolatile RAM memories. Cypress serves numerous major markets, including consumer, mobile handsets, computation, data communications, automotive, industrial and military. Cypress trades on the NASDAQ Global Select Market under the ticker symbol CY. Visit Cypress online at www.cypress.com .

Cypress, the Cypress logo, PSoC, TrueTouch and CapSense are registered trademarks of Cypress Semiconductor Corp. All other trademarks are property of their owners.

Contact: Samer Bahou Cypress PR (408) 232-4552 Email Contact

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Lundbeck's Board Leadership Transitions into New Era

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

UEG's New Advisory Board: Elevating Patient Voices

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Tomorrowland's Shanghai Return: An Electri-Lifesaver

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

ASTS Faces a Legal Countdown – Investors Take Note

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Antheia Secures $80M for Critical Medicine Onshoring

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Class Action Alert for Twitter Stockholders: Important Updates

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Understanding Market Trends Impacting NCR Atleos Corp's Future

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...